Aged Garlic Extract: The Kyolic Evidence for Cardiovascular Risk

← Back to articles

Most garlic supplements are sold on the strength of allicin — the pungent compound produced when fresh garlic is crushed. Aged garlic extract (AGE; the original branded product is Kyolic) is made differently: sliced garlic is soaked in dilute ethanol for up to 20 months, yielding a near-odourless, stable extract with a different (and not necessarily weaker) pharmacology. AGE is one of the better-studied garlic products, with several randomised trials in cardiovascular risk reduction.

Blood Pressure Effect

The Ried 2020 review and meta-analysis in Experimental and Therapeutic Medicine (PMID 32010325; DOI 10.3892/etm.2019.8374) pooled 12 trials (n=553 hypertensive participants) and reported an average systolic blood pressure reduction of 8.3 ± 1.9 mmHg, with diastolic BP reduced by 5.5 ± 1.9 mmHg in the subset of 8 trials (n=374) reporting it. That is in the same range as a single first-line antihypertensive at a low dose. Effects appear most consistent with standardised AGE products specifically and more variable with generic garlic powders.

Coronary Imaging

Several small randomised trials have examined whether AGE slows atherosclerosis on imaging. The Budoff 2009 RCT in Preventive Medicine (PMID 19573556; DOI 10.1016/j.ypmed.2009.06.018) showed slower coronary artery calcium (CAC) progression over 1 year with AGE plus B vitamins and folic acid versus placebo. The Matsumoto 2016 trial in the Journal of Nutrition (PMID 26764322; DOI 10.3945/jn.114.202424) used coronary CT angiography in metabolic-syndrome patients and reported a reduction in low-attenuation (lipid-rich, higher-risk) plaque with AGE 2,400 mg/day. These are among the few supplement trials to use direct imaging endpoints, but cohorts have been small (~50–65 per arm) and the findings still need larger replication before being treated as definitive.

Lipids and Inflammation

AGE produces modest LDL reductions (typically in the 5–10% range) and small reductions in hs-CRP in pooled data. These effects are smaller than statins but appear additive on top of standard therapy. S-allyl-cysteine is the most commonly proposed contributor, with effects on endothelial function and nitric oxide availability.

Safety

AGE is well tolerated, with minimal GI effects and no garlic odour — a practical advantage over fresh garlic for daily use. It has a mild antiplatelet effect, so use caution alongside warfarin, DOACs, or high-dose NSAIDs, and stop 1–2 weeks before scheduled surgery. CYP-enzyme drug interactions are weaker with AGE than with fresh garlic or allicin-yield extracts but still possible.

Dosing

Standard AGE dose in trials is 1,200–2,400 mg/day, usually divided. Look for Kyolic-branded or otherwise standardised AGE products; generic "aged garlic" products vary widely in extraction process and active-compound content. The published efficacy was earned by specific standardised preparations — that is what to buy.